Skip to content

Accu-Chek Fastclix 07531567160Recalls & reported problems

Roche Diabetes Care GmbH · Accu-Chek Fastclix AST Kit USA · Class 2

All models of Accu-Chek Fastclix (4)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00365702702219), received between Oct 20, 2020 and Oct 20, 2020 — classified as 1 malfunction.

The most frequently reported specific device problem is “Retraction Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Retraction Problem1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 20, 2020Retraction Problem; Retraction Problem

    IT WAS REPORTED THAT THE LANCET PROTRUDES BEYOND THE END CAP OF THE DEVICE.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10704561 ↗

Other Multiple Use Blood Lancet For Single Patient Use Only devices

All Multiple Use Blood Lancet For Single Patient Use Only devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page